Pharmaceutical News

RSS

UCLA-led researchers identify potential TB drug regimen that may cut treatment time up to 75%

Taking a new approach toward tuberculosis therapy, a UCLA-led research team has devised a potential drug regimen that could cut the treatment time by up to 75 percent, while simultaneously reducing the risk that patients could develop drug-resistant TB.

25 Jan 2017

Scientists define working mechanism of promising anti-cancer molecules

An international team of scientists, including MIPT researchers, has defined the way their promising anti-cancer molecules work.

25 Jan 2017

New treatment for C.diff infections reduces recurrences by 40%, study finds

A new treatment for Clostridium difficile (C.diff) infections reduces recurrent infections by nearly 40%, a large study has found.

25 Jan 2017

Delaying marijuana use until age 17 can be better for adolescent’s brains, says new study

The more teenagers delay smoking marijuana until they're older, the better it is for their brains, but there may be little ill effect if they start after age 17, says a new Université de Montréal study.

25 Jan 2017

Alternative influenza vaccine may provide clinical benefits and cost savings, study suggests

A study just published in Human Vaccines & Immunotherapeutics suggests that an alternative vaccine might bring clinical benefits and cost savings if used on a large scale when compared to the one currently in widest use.

25 Jan 2017

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

Wilfried Weber, Professor of Synthetic Biology at the University of Freiburg, has received a grant of roughly €150,000 for his project "Hide and Seek with Cancer Drugs" in which he is working to improve the drugs used in cancer treatment

25 Jan 2017

Scientists discover cause of tumour resistance to angiogenesis inhibitors

A new study conducted by MedUni Vienna in collaboration with scientists from Hungary and Sweden has now shown for the first time that the success of specialised drugs to inhibit blood supply to tumours - so-called angiogenesis inhibitors - is compromised by the fact that these drugs do not effectively penetrate the tumour tissue and so do not reach the smallest blood vessels in the tumour.

25 Jan 2017

Functional MRI brain scan may help predict patient’s response to antidepressant therapy

A functional MRI brain scan may help predict which patients will respond positively to antidepressant therapy, according to a new study published in the journal Brain.

25 Jan 2017

TSRI scientists receive $1.8 million grant to develop drug candidates for multiple diseases

Scientists from the Florida campus of The Scripps Research Institute have been awarded approximately $1.8 million from the National Institute of General Medical Sciences of the National Institutes of Health to develop a series of drug candidates for a number of diseases, including heart disease, rheumatoid arthritis and several neurodegenerative disorders.

24 Jan 2017

Dementia patients may often struggle to manage drug regime, study reveals

New research funded by Pharmacy Research UK published on 19 January, reveals people with dementia may struggle with managing their medication - exposing them to side-effects, medication errors and an increased risk of non-adherence to drug treatment.

24 Jan 2017

New drugs that target neighbour proteins may help halt cancer progression

Cancer is caused by an accumulation of genetic changes in a cell, that overcome the normal checks and balances leading to uncontrolled growth. A complex, interacting network of proteins controls all of a cell's processes, from metabolism to growth and division.

24 Jan 2017

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

New research has found spinal cord stimulation (SCS) therapy can be key to reducing or stabilizing the use of opioids in patients battling chronic pain.

20 Jan 2017

Fixed-dose combinations could help patients stick to taking anti-hypertensive medicines

There is value in starting off patients with high blood pressure on an all-in-one pill. In the long run, it may help them stick to taking the potentially life-saving medicines prescribed to them.

20 Jan 2017

New genital herpes vaccine candidate shows promising results in preclinical tests

Approximately 500 million people around the world are infected with the genital herpes virus known as herpes simplex virus 2 (HSV2).

20 Jan 2017

New research exposes cellular responses linked to bird flu vaccine

New research from Vanderbilt eavesdrops on gene expression in human immune system cells before and after vaccination against bird flu.

19 Jan 2017

FDA approves new oral medication for treating chronic idiopathic constipation in adult patients

The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.

19 Jan 2017

Statins could reduce threat of venous thromboembolism, research shows

Statins could hold the key to eradicating one of the most preventable causes of hospital deaths after researchers uncovered a new role for the cholesterol-lowering pill.

19 Jan 2017

Eosera introduces new solution for earwax impaction

EOSERA™, Inc. , a Dallas-based biotechnology innovator founded by two veterans of the pharmaceutical industry, today announced the introduction of Earwax MD—the ideal solution for those who dread the time, worry, and expense of a doctor’s visit to clear their ears of burdensome earwax impaction.

19 Jan 2017

New way of repurposing existing drugs could unearth promising treatments for Parkinson’s disease

By bringing together cutting-edge stem cell technologies and computational biology, researchers at Oxford University have developed a unique way to identify existing drugs that could potentially be repurposed for treating Parkinson’s.

19 Jan 2017

OSU scientists develop new weapon to combat antibiotic-resistant germs

Oregon State University researchers have developed a new weapon in the battle against antibiotic-resistant germs - a molecule that neutralizes the bugs' ability to destroy the antibiotic.

19 Jan 2017

Pharmaceutical News

UCLA-led researchers identify potential TB drug regimen that may cut treatment time up to 75%

Scientists define working mechanism of promising anti-cancer molecules

New treatment for C.diff infections reduces recurrences by 40%, study finds

Delaying marijuana use until age 17 can be better for adolescent’s brains, says new study

Alternative influenza vaccine may provide clinical benefits and cost savings, study suggests

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

Scientists discover cause of tumour resistance to angiogenesis inhibitors

Functional MRI brain scan may help predict patient’s response to antidepressant therapy

TSRI scientists receive $1.8 million grant to develop drug candidates for multiple diseases

Dementia patients may often struggle to manage drug regime, study reveals

New drugs that target neighbour proteins may help halt cancer progression

SCS therapy can be key to reducing use of opioids in patients battling chronic pain, study finds

Fixed-dose combinations could help patients stick to taking anti-hypertensive medicines

New genital herpes vaccine candidate shows promising results in preclinical tests

New research exposes cellular responses linked to bird flu vaccine

FDA approves new oral medication for treating chronic idiopathic constipation in adult patients

Statins could reduce threat of venous thromboembolism, research shows

Eosera introduces new solution for earwax impaction

New way of repurposing existing drugs could unearth promising treatments for Parkinson’s disease

OSU scientists develop new weapon to combat antibiotic-resistant germs

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News